Please use this identifier to cite or link to this item:
|Title:||Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential|
|Publisher:||JOURNAL OF BIOMEDICAL MATERIALS RESEARCH|
|Citation:||JOURNAL OF BIOMEDICAL MATERIALS RESEARCH. 34; 1; 21-28|
|Abstract:||Chitosan, a mucopolysaccharide of marine origin, was studied for its safety and hemostatic potential. Its surface was treated with glutaraldehyde, carbodiimide, and plasma glow discharge to elicit effects of enzyme degradation. Of the seven enzymes used, leucine amino peptidase caused maximum degradation. Autoclaving appeared to be an ideal sterilizing method as it caused least decrease in tensile strength and effected a negligible rate of hemolysis. Sterilizing with glutaraldehyde with a physiologic pH retained the maximum tensile strength of chitosan. In vivo toxicity tests indicated that it is nontoxic, and the sterilized films were free of pyrogen. Coagulation and hemagglutination tests showed that the hemostatic mechanism of chitosan seems to be independent of the classical coagulation cascade and appears to be an interaction between the cell membrane of erythrocytes and chitosan. (C) 1997 John Wiley & Sons, Inc.|
|Appears in Collections:||Journal Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.